NYXH News & Events

Nyxoah announced the signature of a memorandum of understanding, or MoU, with Sheikh Shakhbout Medical City, or SSMC, a hospital in the United Arab Emirates for serious and complex care and a subsidiary of PureHealth. As part of this MoU, Nyxoah and SSMC are engaged in initiatives aimed at positioning SSMC as a regional center for Genio therapy. In parallel, the collaboration includes plans to establish SSMC as a regional training hub for Genio therapy in the Middle East to support the education of surgeons, sleep physicians, and referring healthcare professionals from across the region. Nyxoah and SSMC are also engaged in discussions to explore clinical research and collaboration in the field of sleep apnea, chronic and metabolic disease management.

Nyxoah announced an investment in Belgium to further scale its manufacturing capacity. In addition to its existing contract manufacturing operations in the United States, the company will expand its manufacturing footprint in Wallonia. As part of this investment, Nyxoah has signed an agreement with LegiaPark that will support Nyxoah's product development activities and the creation of a nearly 2,000 square meters manufacturing facility, including a cleanroom, developed in collaboration with ABN Cleanroom Technology.